Diminishing RBM15 levels demonstrated the capacity to impede the growth and proliferation of CML cells, impede the cell cycle, and induce apoptosis (68). This evidence concerns the gene RBM15 and chronic myelogenous leukemia, BCR-ABL1 positive.